| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ivan P Jovanovic | Q56997852 |
| P2093 | author name string | J Michael Conlon | |
| Miodrag L Lukic | |||
| Nebojsa N Arsenijevic | |||
| Gordana D Radosavljevic | |||
| Jelena M Pantic | |||
| P2860 | cites work | Interleukin-10 and the interleukin-10 receptor | Q24290912 |
| Trial Watch-Immunostimulation with cytokines in cancer therapy | Q28078725 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| M-1/M-2 macrophages and the Th1/Th2 paradigm | Q28145893 | ||
| The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing? | Q28548287 | ||
| Host-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidae | Q28659477 | ||
| Functions of natural killer cells | Q29614300 | ||
| Conformational analysis of the frog skin peptide, plasticin-L1, and its effects on production of proinflammatory cytokines by macrophages. | Q30670493 | ||
| Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 | ||
| Peptidomic analysis of skin secretions demonstrates that the allopatric populations of Xenopus muelleri (Pipidae) are not conspecific. | Q33929878 | ||
| Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents | Q80459060 | ||
| Antimicrobial peptides from the skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae) | Q82264754 | ||
| A short peptide from frog skin accelerates diabetic wound healing | Q87562039 | ||
| Th1 and Th17 cells: adversaries and collaborators | Q34038557 | ||
| Antimicrobial peptides and wound healing: biological and therapeutic considerations | Q34507671 | ||
| A cytokine-mediated link between innate immunity, inflammation, and cancer | Q34625152 | ||
| Control of cell selectivity of antimicrobial peptides | Q34865746 | ||
| Cytokine-based immunointervention in the treatment of autoimmune diseases | Q35109131 | ||
| Microbiota and mucosal immunity in amphibians | Q35172851 | ||
| Mycobacterium liflandii outbreak in a research colony of Xenopus (Silurana) tropicalis frogs | Q35206412 | ||
| Antimicrobial peptides in human skin | Q36173714 | ||
| APD3: the antimicrobial peptide database as a tool for research and education | Q36434966 | ||
| Temporins, anti-infective peptides with expanding properties | Q36435250 | ||
| Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment | Q36543072 | ||
| Agents from amphibians with anticancer properties | Q37283251 | ||
| NK cells and cancer immunosurveillance. | Q37287176 | ||
| The roles of antimicrobial peptides in innate host defense | Q37361213 | ||
| Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides | Q37385746 | ||
| Comparative and developmental study of the immune system in Xenopus | Q37404751 | ||
| Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics | Q37414152 | ||
| Peptide design for antimicrobial and immunomodulatory applications | Q37598400 | ||
| The contribution of skin antimicrobial peptides to the system of innate immunity in anurans. | Q37773817 | ||
| Alpha-helical cationic antimicrobial peptides: relationships of structure and function | Q37825833 | ||
| Structural diversity and species distribution of host-defense peptides in frog skin secretions | Q37874199 | ||
| Multifunctional cationic host defence peptides and their clinical applications | Q37875767 | ||
| Host-defense peptides: from biology to therapeutic strategies | Q37876361 | ||
| β-Defensins: multifunctional modulators of infection, inflammation and more? | Q37996291 | ||
| Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides | Q38160482 | ||
| Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents | Q38209134 | ||
| Host defense peptides: front-line immunomodulators | Q38239034 | ||
| The chemistry and biological activities of peptides from amphibian skin secretions | Q38320713 | ||
| An immunomodulatory peptide related to frenatin 2 from skin secretions of the Tyrrhenian painted frog Discoglossus sardus (Alytidae). | Q38428473 | ||
| Esculentin-2CHa(1-30) and its analogues: stability and mechanisms of insulinotropic action. | Q38719823 | ||
| The frog skin host-defense peptide frenatin 2.1S enhances recruitment, activation and tumoricidal capacity of NK cells | Q38773856 | ||
| Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa. | Q38935461 | ||
| Esculentin-2CHa: a host-defense peptide with differential cytotoxicity against bacteria, erythrocytes and tumor cells. | Q39243565 | ||
| Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent | Q39281555 | ||
| Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7. | Q39972350 | ||
| A potent, non-toxic insulin-releasing peptide isolated from an extract of the skin of the Asian frog, Hylarana guntheri (Anura:Ranidae). | Q39978895 | ||
| Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris | Q40023939 | ||
| In vivo administration of the frog skin peptide frenatin 2.1S induces immunostimulatory phenotypes of mouse mononuclear cells | Q41090928 | ||
| Antimicrobial and immunomodulatory properties of PGLa-AM1, CPF-AM1, and magainin-AM1: potent activity against oral pathogens. | Q41635865 | ||
| Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells | Q41853652 | ||
| Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae). | Q41990453 | ||
| Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus. | Q42491182 | ||
| Purification, Conformational Analysis, and Properties of a Family of Tigerinin Peptides from Skin Secretions of the Crowned Bullfrog Hoplobatrachus occipitalis. | Q42498137 | ||
| The hymenochirins: a family of host-defense peptides from the Congo dwarf clawed frog Hymenochirus boettgeri (Pipidae). | Q42718922 | ||
| Antimicrobial peptides isolated from skin secretions of the diploid frog, Xenopus tropicalis (Pipidae). | Q43818649 | ||
| Effects of tigerinin peptides on cytokine production by mouse peritoneal macrophages and spleen cells and by human peripheral blood mononuclear cells | Q44518754 | ||
| Characterization of antimicrobial peptides in skin secretions from discrete populations of Lithobates chiricahuensis (Ranidae) from central and southern Arizona. | Q44540731 | ||
| The ascaphins: a family of antimicrobial peptides from the skin secretions of the most primitive extant frog, Ascaphus truei. | Q44787161 | ||
| Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes | Q45007550 | ||
| The alyteserins: two families of antimicrobial peptides from the skin secretions of the midwife toad Alytes obstetricans (Alytidae). | Q45948317 | ||
| Evidence from peptidomic analysis of skin secretions that the red-legged frogs, Rana aurora draytonii and Rana aurora aurora, are distinct species. | Q45957136 | ||
| An analog of the host-defense peptide hymenochirin-1B with potent broad-spectrum activity against multidrug-resistant bacteria and immunomodulatory properties. | Q46033310 | ||
| Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae). | Q46044092 | ||
| Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream | Q46260034 | ||
| Peptidomic analysis of skin secretions of the Mexican burrowing toad Rhinophrynus dorsalis (Rhinophrynidae): Insight into the origin of host-defense peptides within the Pipidae and characterization of a proline-arginine-rich peptide. | Q46300239 | ||
| Characterization of the host-defense peptides from skin secretions of Merlin's clawed frog Pseudhymenochirus merlini: insights into phylogenetic relationships among the Pipidae | Q46583604 | ||
| A family of antimicrobial and immunomodulatory peptides related to the frenatins from skin secretions of the Orinoco lime frog Sphaenorhynchus lacteus (Hylidae). | Q46846133 | ||
| OM-LV20, a novel peptide from odorous frog skin, accelerates wound healing in vitro and in vivo. | Q48222393 | ||
| Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy | Q50195544 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peptide | Q172847 |
| neoplasm | Q1216998 | ||
| interleukins | Q194908 | ||
| anti-inflammatory agent | Q581996 | ||
| amphibian proteins | Q58622852 | ||
| Frog skin active peptide family | Q41796591 | ||
| immunologic factor | Q50349184 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2017-12-13 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents | |
| P478 | volume | 22 |
| Q89927176 | Antimicrobial host defence peptides: functions and clinical potential |
| Q91801396 | Biofilms: Novel Strategies Based on Antimicrobial Peptides |
| Q89170496 | Expression, Purification, and Characterization of a Novel Hybrid Peptide with Potent Antibacterial Activity |
| Q90053087 | In vitro and intracellular activities of frog skin temporins against Legionella pneumophila and its eukaryotic hosts |
| Q59356042 | Unveiling the Multifaceted Mechanisms of Antibacterial Activity of Buforin II and Frenatin 2.3S Peptides from Skin Micro-Organs of the Orinoco Lime Treefrog () |
Search more.